HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target

Benzinga · 10/15 09:53
HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 price target.